Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ZFYVE26 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ERAP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRIM38 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BTN3A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
MX2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IRF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GBP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CMTR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BTN3A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TNFSF10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IFNL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AKR1C3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRANK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIF13A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
APOL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NAPA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GIMAP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on